Melatonin Pharma Nord

Melatonin, the active ingredient in Melatonin Pharma Nord, is a melatonin receptor agonist presented as an oral dosage form for oral use. It helps regulate the sleep‑wake cycle and is used to manage insomnia, circadian rhythm disturbances, and jet lag in adults. GNH USA supplies Melatonin Pharma Nord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Pharma Nord acts on melatonin receptors to support normal sleep regulation. - Insomnia: improves sleep onset and maintenance in individuals with difficulty falling or staying asleep. - Sleep‑wake rhythm disorders: helps synchronize disrupted circadian rhythms, such as shift‑work disorder. - Jet lag: reduces the time needed to adjust to new time zones after rapid travel.

Melatonin Pharma Nord may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness during daytime - Headache - Dizziness - Nausea - Vivid dreams or nightmares

Serious or Rare Side Effects: - Allergic skin reactions (rash, itching, swelling) - Mood changes (depression, anxiety) - Hormonal effects (menstrual irregularities) - Severe hypersensitivity (anaphylaxis)

Before using Melatonin Pharma Nord, consider the following safety points. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential exposure with a physician. - Pediatric use: generally not recommended without specialist advice. - Concomitant sedatives: monitor for enhanced drowsiness. - Underlying medical conditions: inform the prescriber of liver or kidney disease. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Melatonin may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants/antiplatelets: increased bleeding risk. - Immunosuppressants (e.g., cyclosporine): reduced immunosuppressive effect.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, barbiturates): additive sedation. - Oral contraceptives: possible reduction in melatonin metabolism. - Antidiabetic agents: potential alteration of glucose control.